← Eichor
Condition: Breast Cancer Treated With Neoadjuvant Chemotherapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Breast Cancer Treated With Neoadjuvant Chemotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvan
Phase 2 · 1 location(s) · RemeGen Co., Ltd. · NCT06389006Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatm
Phase 2 · 1 location(s) · University of Washington · NCT04329065Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)
Phase 2 · 3 location(s) · First Affiliated Hospital of Zhejiang University · NCT06874933Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
NA · 2 location(s) · European Institute of Oncology · NCT06281210Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
Phase 3 · 3 location(s) · City of Hope Medical Center · NCT06763328I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Phase 2 · 42 location(s) · QuantumLeap Healthcare Collaborative · NCT01042379Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
Phase 2 · 13 location(s) · First Affiliated Hospital of Zhejiang University · NCT06682195A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05412225Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breas
Phase 2/Phase 3 · 30 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT03150576Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
Phase N/A · 1 location(s) · Hunan Cancer Hospital · NCT05326295Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Res
NA · 1 location(s) · Peking Union Medical College Hospital · NCT06908291Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support t
NA · 1 location(s) · Hospital Clinic of Barcelona · NCT07107594Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy
Phase N/A · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT07260188Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neo
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07113613Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer
Phase 2 · 1 location(s) · Zhenzhen Liu · NCT05475678Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant T
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06908668Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · 544 location(s) · National Cancer Institute (NCI) · NCT06058377AXillary Surgery After NeoAdjuvant Treatment
Phase N/A · 1 location(s) · European Breast Cancer Research Association of Surgical Tria · NCT04373655Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy
NA · 98 location(s) · University Hospitals of Derby and Burton NHS Foundation Trus · NCT04109079Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete
NA · 1 location(s) · Hospices Civils de Lyon · NCT06299202
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.